Healthcare Companies
Current = Existing New Markets company
Previous = Previous investment by New Markets principal
 |
Proprietary regenerative cell therapies that target significant unmet medical needs. Current. |
 |
Live attenuated influenza vaccines including FluMist, (Acquired by MedImmune) Previous. |
 |
Peptides designed to enhance the body’s biologic response to medical device implants. Current. |
 |
Urine sample test for HIV-1 (NASDAQ: CBMC) Previous. |
 |
Cryospray ablation medical device technology for gastrointestinal cancer. Current. |
 |
Transatlantic CRO that expedites high quality, cost-effective clinical trials. Previous. |
 |
Designer and manufacturer of simulation technology for medical training. Previous. |
 |
Rapid, portable testing systems for the detection of pathogens. Current. |
 |
Small molecule therapeutics and delivery system for rheumatoid arthritis, Crohn's and asthma. Current. |
 |
Image-guided surgery system for the biopsy and ablation of tumors. Previous. |